pre-update Archives

On-Demand Webinar

Quantitative Systems Pharmacology for Drug Discovery and Development

Certara's Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University,…

CertaraMarch 2, 2021

Blog

The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers

By: James Zoshak The COVID-19 pandemic has added increased risk and uncertainty to gene therapy…

CertaraFebruary 22, 2021

Brochure

Gene Therapy Platform using Certara’s Virtual Twin® Technology

CertaraFebruary 22, 2021

Blog

Why Consistency in Patient Safety Narratives is Crucial

“You would not be able to tell 40 different writers were authoring these. It looked…

CertaraFebruary 9, 2021

Publication

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…

CertaraFebruary 9, 2021

On-Demand Webinar

RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing

Narratives are an integral part of medical writing. Sponsors sometimes need to prepare large…

CertaraFebruary 8, 2021

Blog

8 Tips for Successfully Developing Oligonucleotide Therapies

By Eva Gil Berglund and Nathalie H Gosselin Oligonucleotide therapeutics are a validated class of…

CertaraFebruary 1, 2021

Brochure

BaseCase Interactive for Medical Affairs

CertaraJanuary 28, 2021

On-Demand Webinar

How drug developers can avoid these common mistakes to secure a deal

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

On-Demand Webinar

Making your biotech program investor-ready

Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…

CertaraJanuary 21, 2021

pre-update

Quantitative Systems Pharmacology for Drug Discovery and Development

The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers

Gene Therapy Platform using Certara’s Virtual Twin® Technology

Why Consistency in Patient Safety Narratives is Crucial

BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection

RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing

8 Tips for Successfully Developing Oligonucleotide Therapies

BaseCase Interactive for Medical Affairs

How drug developers can avoid these common mistakes to secure a deal

Making your biotech program investor-ready

Newsletter sign up

Quick links

Solutions

Contact